Literature DB >> 10087196

Genomic organization and biological characterization of the novel human CC chemokine DC-CK-1/PARC/MIP-4/SCYA18.

P Guan1, A H Burghes, A Cunningham, P Lira, W H Brissette, K Neote, S R McColl.   

Abstract

The chemokines are a group of chemotactic molecules that appear to regulate the directed movement of white blood cells in vitro and in vivo and may therefore play important roles in inflammation and immunity. The genes encoding the chemokines are clustered in close physical proximity to each other. A large cluster of human CC chemokine genes resides on chromosome 17. We have used this information in a positional cloning approach to identify novel chemokine genes within this cluster. We constructed a YAC contig encompassing the MIP-1alpha (HGMW-approved symbol SCYA3) gene region and used exon trapping and sequence analysis to isolate novel chemokine genes. Using this approach, a gene encoding a chemokine named MIP-4, based on its homology with MIP-1alpha (49.5% identity at the nucleotide level and 59.6% at the predicted amino acid level), was found. The MIP-4 gene (HGMW-approved symbol SCYA18) consists of three exons spread over 7.1 kb and is separated from the MIP-1alpha gene by 16 kb. The MIP-4 gene encodes a 750-bp mRNA that is expressed in lung and macrophages but not in brain or muscle. The mRNA encodes an 89-amino-acid protein and includes a predicted signal peptide of 21 amino acids. Recombinant or synthetic MIP-4 induced calcium mobilization in naive and activated T lymphocyte subpopulations in vitro. Injection of synthetic MIP-4 into the peritoneal cavity of mice led to the accumulation of both CD4(+) and CD8(+) T lymphocytes, but not monocytes or granulocytes. These observations provide new information concerning the arrangement of the CC chemokine gene cluster on human chromosome 17 and indicate that the MIP-4 gene product is chemotactic in vivo for both CD4(+) and CD8(+) T lymphocytes and may therefore be implicated in both humoral and cell-mediated immunity. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10087196     DOI: 10.1006/geno.1998.5635

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  15 in total

1.  Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Sarah Peterson; Julie A Poposki; Deepti R Nagarkar; Regina T Chustz; Anju T Peters; Lydia A Suh; Roderick Carter; James Norton; Kathleen E Harris; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2011-09-23       Impact factor: 10.793

2.  PKCalpha mediates CCL18-stimulated collagen production in pulmonary fibroblasts.

Authors:  Irina G Luzina; Kendrick Highsmith; Kerill Pochetuhen; Natalia Nacu; Jaladanki N Rao; Sergei P Atamas
Journal:  Am J Respir Cell Mol Biol       Date:  2006-04-06       Impact factor: 6.914

Review 3.  Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes.

Authors:  Evemie Schutyser; Ann Richmond; Jo Van Damme
Journal:  J Leukoc Biol       Date:  2005-03-22       Impact factor: 4.962

4.  Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir.

Authors:  Michael Lu; Jacqueline Suen; Carolina Frias; Ruth Pfeiffer; Mong-Hsun Tsai; Eric Chuang; Steven L Zeichner
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Transcript signatures of lymphocytic bronchitis in lung allograft biopsy specimens.

Authors:  Xiang Xu; Jeffrey A Golden; Gregory Dolganov; Kirk D Jones; Samantha Donnelly; Timothy Weaver; George H Caughey
Journal:  J Heart Lung Transplant       Date:  2005-08       Impact factor: 10.247

6.  CCL18 production is decreased in alveolar macrophages from cigarette smokers.

Authors:  Florian Kollert; Corina Probst; Joachim Müller-Quernheim; Gernot Zissel; Antje Prasse
Journal:  Inflammation       Date:  2009-06       Impact factor: 4.092

7.  PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.

Authors:  Sofie Struyf; Evemie Schutyser; Mieke Gouwy; Klara Gijsbers; Paul Proost; Yves Benoit; Ghislain Opdenakker; Jo Van Damme; Geneviève Laureys
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

8.  Complex regulation of pulmonary inflammation and fibrosis by CCL18.

Authors:  Kerill Pochetuhen; Irina G Luzina; Virginia Lockatell; Jung Choi; Nevins W Todd; Sergei P Atamas
Journal:  Am J Pathol       Date:  2007-06-14       Impact factor: 4.307

9.  Protein microarray analysis in patients with asthma: elevation of the chemokine PARC/CCL18 in sputum.

Authors:  Hyo-Bin Kim; Chang-Keun Kim; Koji Iijima; Takao Kobayashi; Hirohito Kita
Journal:  Chest       Date:  2008-11-18       Impact factor: 9.410

10.  PARC/CCL18 is Associated with Inflammation, Emphysema Severity and Application of Inhaled Corticosteroids in Hospitalized COPD Patients.

Authors:  Hongxia Duan; Long Liang; Xinyang Liu; Shuanshuan Xie; Changhui Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.